Loading…

Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation

The usefulness of routine axillary dissection (AD) at levels I-II in breast cancer patients has been questioned for years because of the high postoperative morbidity in the shoulder and arm region, and the increasing number of patients with negative nodes. Sentinel node biopsy (SNB) was hoped both t...

Full description

Saved in:
Bibliographic Details
Published in:Breast cancer research and treatment 2002-05, Vol.73 (1), p.31-36
Main Authors: HAID, Anton, KÖBERLE-WÜHRER, Roswitha, ZIMMERMANN, Gerhard, KNAUER, Michael, BURTSCHER, Judit, FRITZSCHE, Heinz, PESCHINA, William, JASAREVIC, Zerina, AMMANN, Maria, HERGAN, Klaus, STURN, Heinz
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03
cites cdi_FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03
container_end_page 36
container_issue 1
container_start_page 31
container_title Breast cancer research and treatment
container_volume 73
creator HAID, Anton
KÖBERLE-WÜHRER, Roswitha
ZIMMERMANN, Gerhard
KNAUER, Michael
BURTSCHER, Judit
FRITZSCHE, Heinz
PESCHINA, William
JASAREVIC, Zerina
AMMANN, Maria
HERGAN, Klaus
STURN, Heinz
description The usefulness of routine axillary dissection (AD) at levels I-II in breast cancer patients has been questioned for years because of the high postoperative morbidity in the shoulder and arm region, and the increasing number of patients with negative nodes. Sentinel node biopsy (SNB) was hoped both to reduce morbidity and to improve the reliability of staging. This study was designed to provide more evidence in this matter by comparing the follow-up data of patients with AD and those with SNB only. One hundred forty patients who had undergone AD between 1993 and 1996 were questioned for their subjective and objective symptoms using a questionnaire and subsequently subjected to a clinical examination. Their data were compared with those of 57 patients who had undergone SNB only between 1998 and 2000. Local recurrences have not been seen to date. The difference between the two groups in terms of a loss of quality of life was negligible. The differences in overall complaints, number of symptoms, pain, limited range of motion of the operated upper extremity, numbness, paresthesias, and arm swelling as well as perceived disability in activities of daily living were significantly in favor of SNB. The length of hospital stay was significantly shorter for SNB patients. SNB appears to be an accurate procedure for axillary nodal staging in breast cancer patients and is associated with reduced postoperative morbidity and length of hospital stay. But it is still investigational and should not be implemented as therapeutical standard before results of randomized trials are published.
doi_str_mv 10.1023/A:1015234318582
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71849575</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>405244721</sourcerecordid><originalsourceid>FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi1ERbeFMzdkIdFbqD_iOO5tVbWAVMQFztHYGSNX3jjYScse-ed16UoVnHx53mfG8xLylrOPnAl5vr3gjCshW8l71YsXZMOVlo0WXL8kG8Y73XQ9647JSSm3jDGjmXlFjrlgveyE2ZA_X1O2YQzLniZPbUYoC3UwOcx0hiXgtBTqU4zpPkw_qUu7OeKCFH6HGCHv6RhKQbeENNGUaal8mDDSKY1IbUhzqeIp7i8o_A1DrtI7pHgHcYXH2Gty5CEWfHN4T8mP66vvl5-bm2-fvlxubxonFVsaaYVhHnQ7tiNzSrfKIJjWeO40OmHBA-NgO2NH8FZKZ523lltmpeMWmTwlZ0_eOadfK5Zl2IXisP5iwrSWQfO-NUqrCr7_D7xNa57qboPgolWy67sKnT9BLqdSMvphzmFXDzJwNjxWM2yHf6qpiXcH7Wp3OD7zhy4q8OEAQHEQfa4thPLM1bnaVOEDYFOZ1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212453686</pqid></control><display><type>article</type><title>Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation</title><source>Springer Link</source><creator>HAID, Anton ; KÖBERLE-WÜHRER, Roswitha ; ZIMMERMANN, Gerhard ; KNAUER, Michael ; BURTSCHER, Judit ; FRITZSCHE, Heinz ; PESCHINA, William ; JASAREVIC, Zerina ; AMMANN, Maria ; HERGAN, Klaus ; STURN, Heinz</creator><creatorcontrib>HAID, Anton ; KÖBERLE-WÜHRER, Roswitha ; ZIMMERMANN, Gerhard ; KNAUER, Michael ; BURTSCHER, Judit ; FRITZSCHE, Heinz ; PESCHINA, William ; JASAREVIC, Zerina ; AMMANN, Maria ; HERGAN, Klaus ; STURN, Heinz</creatorcontrib><description>The usefulness of routine axillary dissection (AD) at levels I-II in breast cancer patients has been questioned for years because of the high postoperative morbidity in the shoulder and arm region, and the increasing number of patients with negative nodes. Sentinel node biopsy (SNB) was hoped both to reduce morbidity and to improve the reliability of staging. This study was designed to provide more evidence in this matter by comparing the follow-up data of patients with AD and those with SNB only. One hundred forty patients who had undergone AD between 1993 and 1996 were questioned for their subjective and objective symptoms using a questionnaire and subsequently subjected to a clinical examination. Their data were compared with those of 57 patients who had undergone SNB only between 1998 and 2000. Local recurrences have not been seen to date. The difference between the two groups in terms of a loss of quality of life was negligible. The differences in overall complaints, number of symptoms, pain, limited range of motion of the operated upper extremity, numbness, paresthesias, and arm swelling as well as perceived disability in activities of daily living were significantly in favor of SNB. The length of hospital stay was significantly shorter for SNB patients. SNB appears to be an accurate procedure for axillary nodal staging in breast cancer patients and is associated with reduced postoperative morbidity and length of hospital stay. But it is still investigational and should not be implemented as therapeutical standard before results of randomized trials are published.</description><identifier>ISSN: 0167-6806</identifier><identifier>EISSN: 1573-7217</identifier><identifier>DOI: 10.1023/A:1015234318582</identifier><identifier>PMID: 12083629</identifier><identifier>CODEN: BCTRD6</identifier><language>eng</language><publisher>Dordrecht: Springer</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Axilla ; Biological and medical sciences ; Breast cancer ; Breast Neoplasms - diagnosis ; Breast Neoplasms - epidemiology ; Cancer research ; Cancer therapies ; Female ; Follow-Up Studies ; Gynecology. Andrology. Obstetrics ; Humans ; Lymph Node Excision ; Lymph Nodes - pathology ; Mammary gland diseases ; Mastectomy ; Medical sciences ; Middle Aged ; Neoplasm Staging ; Sentinel Lymph Node Biopsy ; Tumors</subject><ispartof>Breast cancer research and treatment, 2002-05, Vol.73 (1), p.31-36</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Kluwer Academic Publishers May 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03</citedby><cites>FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13687952$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12083629$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HAID, Anton</creatorcontrib><creatorcontrib>KÖBERLE-WÜHRER, Roswitha</creatorcontrib><creatorcontrib>ZIMMERMANN, Gerhard</creatorcontrib><creatorcontrib>KNAUER, Michael</creatorcontrib><creatorcontrib>BURTSCHER, Judit</creatorcontrib><creatorcontrib>FRITZSCHE, Heinz</creatorcontrib><creatorcontrib>PESCHINA, William</creatorcontrib><creatorcontrib>JASAREVIC, Zerina</creatorcontrib><creatorcontrib>AMMANN, Maria</creatorcontrib><creatorcontrib>HERGAN, Klaus</creatorcontrib><creatorcontrib>STURN, Heinz</creatorcontrib><title>Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation</title><title>Breast cancer research and treatment</title><addtitle>Breast Cancer Res Treat</addtitle><description>The usefulness of routine axillary dissection (AD) at levels I-II in breast cancer patients has been questioned for years because of the high postoperative morbidity in the shoulder and arm region, and the increasing number of patients with negative nodes. Sentinel node biopsy (SNB) was hoped both to reduce morbidity and to improve the reliability of staging. This study was designed to provide more evidence in this matter by comparing the follow-up data of patients with AD and those with SNB only. One hundred forty patients who had undergone AD between 1993 and 1996 were questioned for their subjective and objective symptoms using a questionnaire and subsequently subjected to a clinical examination. Their data were compared with those of 57 patients who had undergone SNB only between 1998 and 2000. Local recurrences have not been seen to date. The difference between the two groups in terms of a loss of quality of life was negligible. The differences in overall complaints, number of symptoms, pain, limited range of motion of the operated upper extremity, numbness, paresthesias, and arm swelling as well as perceived disability in activities of daily living were significantly in favor of SNB. The length of hospital stay was significantly shorter for SNB patients. SNB appears to be an accurate procedure for axillary nodal staging in breast cancer patients and is associated with reduced postoperative morbidity and length of hospital stay. But it is still investigational and should not be implemented as therapeutical standard before results of randomized trials are published.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Axilla</subject><subject>Biological and medical sciences</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - epidemiology</subject><subject>Cancer research</subject><subject>Cancer therapies</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Lymph Node Excision</subject><subject>Lymph Nodes - pathology</subject><subject>Mammary gland diseases</subject><subject>Mastectomy</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Sentinel Lymph Node Biopsy</subject><subject>Tumors</subject><issn>0167-6806</issn><issn>1573-7217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNpdkU1v1DAQhi1ERbeFMzdkIdFbqD_iOO5tVbWAVMQFztHYGSNX3jjYScse-ed16UoVnHx53mfG8xLylrOPnAl5vr3gjCshW8l71YsXZMOVlo0WXL8kG8Y73XQ9647JSSm3jDGjmXlFjrlgveyE2ZA_X1O2YQzLniZPbUYoC3UwOcx0hiXgtBTqU4zpPkw_qUu7OeKCFH6HGCHv6RhKQbeENNGUaal8mDDSKY1IbUhzqeIp7i8o_A1DrtI7pHgHcYXH2Gty5CEWfHN4T8mP66vvl5-bm2-fvlxubxonFVsaaYVhHnQ7tiNzSrfKIJjWeO40OmHBA-NgO2NH8FZKZ523lltmpeMWmTwlZ0_eOadfK5Zl2IXisP5iwrSWQfO-NUqrCr7_D7xNa57qboPgolWy67sKnT9BLqdSMvphzmFXDzJwNjxWM2yHf6qpiXcH7Wp3OD7zhy4q8OEAQHEQfa4thPLM1bnaVOEDYFOZ1Q</recordid><startdate>20020501</startdate><enddate>20020501</enddate><creator>HAID, Anton</creator><creator>KÖBERLE-WÜHRER, Roswitha</creator><creator>ZIMMERMANN, Gerhard</creator><creator>KNAUER, Michael</creator><creator>BURTSCHER, Judit</creator><creator>FRITZSCHE, Heinz</creator><creator>PESCHINA, William</creator><creator>JASAREVIC, Zerina</creator><creator>AMMANN, Maria</creator><creator>HERGAN, Klaus</creator><creator>STURN, Heinz</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20020501</creationdate><title>Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation</title><author>HAID, Anton ; KÖBERLE-WÜHRER, Roswitha ; ZIMMERMANN, Gerhard ; KNAUER, Michael ; BURTSCHER, Judit ; FRITZSCHE, Heinz ; PESCHINA, William ; JASAREVIC, Zerina ; AMMANN, Maria ; HERGAN, Klaus ; STURN, Heinz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Axilla</topic><topic>Biological and medical sciences</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - epidemiology</topic><topic>Cancer research</topic><topic>Cancer therapies</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Lymph Node Excision</topic><topic>Lymph Nodes - pathology</topic><topic>Mammary gland diseases</topic><topic>Mastectomy</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Sentinel Lymph Node Biopsy</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HAID, Anton</creatorcontrib><creatorcontrib>KÖBERLE-WÜHRER, Roswitha</creatorcontrib><creatorcontrib>ZIMMERMANN, Gerhard</creatorcontrib><creatorcontrib>KNAUER, Michael</creatorcontrib><creatorcontrib>BURTSCHER, Judit</creatorcontrib><creatorcontrib>FRITZSCHE, Heinz</creatorcontrib><creatorcontrib>PESCHINA, William</creatorcontrib><creatorcontrib>JASAREVIC, Zerina</creatorcontrib><creatorcontrib>AMMANN, Maria</creatorcontrib><creatorcontrib>HERGAN, Klaus</creatorcontrib><creatorcontrib>STURN, Heinz</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Breast cancer research and treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HAID, Anton</au><au>KÖBERLE-WÜHRER, Roswitha</au><au>ZIMMERMANN, Gerhard</au><au>KNAUER, Michael</au><au>BURTSCHER, Judit</au><au>FRITZSCHE, Heinz</au><au>PESCHINA, William</au><au>JASAREVIC, Zerina</au><au>AMMANN, Maria</au><au>HERGAN, Klaus</au><au>STURN, Heinz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation</atitle><jtitle>Breast cancer research and treatment</jtitle><addtitle>Breast Cancer Res Treat</addtitle><date>2002-05-01</date><risdate>2002</risdate><volume>73</volume><issue>1</issue><spage>31</spage><epage>36</epage><pages>31-36</pages><issn>0167-6806</issn><eissn>1573-7217</eissn><coden>BCTRD6</coden><abstract>The usefulness of routine axillary dissection (AD) at levels I-II in breast cancer patients has been questioned for years because of the high postoperative morbidity in the shoulder and arm region, and the increasing number of patients with negative nodes. Sentinel node biopsy (SNB) was hoped both to reduce morbidity and to improve the reliability of staging. This study was designed to provide more evidence in this matter by comparing the follow-up data of patients with AD and those with SNB only. One hundred forty patients who had undergone AD between 1993 and 1996 were questioned for their subjective and objective symptoms using a questionnaire and subsequently subjected to a clinical examination. Their data were compared with those of 57 patients who had undergone SNB only between 1998 and 2000. Local recurrences have not been seen to date. The difference between the two groups in terms of a loss of quality of life was negligible. The differences in overall complaints, number of symptoms, pain, limited range of motion of the operated upper extremity, numbness, paresthesias, and arm swelling as well as perceived disability in activities of daily living were significantly in favor of SNB. The length of hospital stay was significantly shorter for SNB patients. SNB appears to be an accurate procedure for axillary nodal staging in breast cancer patients and is associated with reduced postoperative morbidity and length of hospital stay. But it is still investigational and should not be implemented as therapeutical standard before results of randomized trials are published.</abstract><cop>Dordrecht</cop><pub>Springer</pub><pmid>12083629</pmid><doi>10.1023/A:1015234318582</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0167-6806
ispartof Breast cancer research and treatment, 2002-05, Vol.73 (1), p.31-36
issn 0167-6806
1573-7217
language eng
recordid cdi_proquest_miscellaneous_71849575
source Springer Link
subjects Adult
Aged
Aged, 80 and over
Axilla
Biological and medical sciences
Breast cancer
Breast Neoplasms - diagnosis
Breast Neoplasms - epidemiology
Cancer research
Cancer therapies
Female
Follow-Up Studies
Gynecology. Andrology. Obstetrics
Humans
Lymph Node Excision
Lymph Nodes - pathology
Mammary gland diseases
Mastectomy
Medical sciences
Middle Aged
Neoplasm Staging
Sentinel Lymph Node Biopsy
Tumors
title Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T09%3A21%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Morbidity%20of%20breast%20cancer%20patients%20following%20complete%20axillary%20dissection%20or%20sentinel%20node%20biopsy%20only:%20a%20comparative%20evaluation&rft.jtitle=Breast%20cancer%20research%20and%20treatment&rft.au=HAID,%20Anton&rft.date=2002-05-01&rft.volume=73&rft.issue=1&rft.spage=31&rft.epage=36&rft.pages=31-36&rft.issn=0167-6806&rft.eissn=1573-7217&rft.coden=BCTRD6&rft_id=info:doi/10.1023/A:1015234318582&rft_dat=%3Cproquest_cross%3E405244721%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c350t-3b290fa74d4d0c57459ea949f1c7ec2bafa01ab69bdafb33cbcfbb1b0b3c1be03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=212453686&rft_id=info:pmid/12083629&rfr_iscdi=true